During the past decade, Crossroads Cancer Center conducted 247 clinical trials. In the 10-year time frame, 247 clinical trials started and 106 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 117 clinical trials started and 89 clinical trials were completed. i.e. 76.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Crossroads Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 138 trials, followed by "SWOG Cancer Research Network" with 58 trials sponsored, "Alliance for Clinical Trials in Oncology" with 43 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "NRG Oncology" with 24 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Crossroads Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 169 trials as a collaborator, "NRG Oncology" with 34 trials as a collaborator, "Canadian Cancer Trials Group" with 14 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Crossroads Cancer Center" are "Stage IV Lung Cancer AJCC v8" (14 trials), "Breast Cancer" (10 trials), "Recurrent Lung Non-Small Cell Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Crossroads Cancer Center" in a lesser frequency.

Most popular intervention types in "Crossroads Cancer Center" are "Drug" (247 trials), "Other" (193 trials), "Biological" (119 trials), "Procedure" (86 trials) and "Radiation" (65 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (85 trials), "Laboratory Biomarker Analysis" (76 trials), "Questionnaire Administration" (61 trials), "Computed Tomography" (47 trials) and "Biospecimen Collection" (44 trials). Other intervention names were less common.

The vast majority of trials in "Crossroads Cancer Center" are 255 trials for "All" genders, 46 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "Crossroads Cancer Center". undefined are not yet recruiting, 107 are recruiting, 134 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Crossroads Cancer Center, 11 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Crossroads Cancer Center, 13 "Phase 1" clinical trials were conducted, 167 "Phase 2" clinical trials and 158 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".